For the Inventor, By the Inventor

Enter assignee name

Smithkline-Rit

USPTO Granted Patents = 14

Forward Citations = 228

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Michele Lobmann (5 out of 5 patents)

Nathan Zygraich (4 out of 6 patents)

Gerard Florent (3 out of 3 patents)

4. Alex J Bollen (2 out of 3 patents)

5. Jean-Claude Delgoffe (2 out of 2 patents)

6. Marc Hoylaerts (1 out of 2 patents)

7. Paul Jacobs (1 out of 3 patents)

8. Nigel Harford (1 out of 2 patents)

9. Jacqueline Gits (1 out of 3 patents)

10. Lucia Dobrescu (1 out of 3 patents)

11. Guy Simonet (1 out of 4 patents)

12. Frans Van Wijnendaele (1 out of 3 patents)

13. Frans V Wijnendaele (1 out of 2 patents)

14. Robert De Neys (1 out of 1 patent)

15. Jean Vandevelde (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 4828988 - Hybrid polypeptides comprising somatocrinine and alpha.sub.1 (1989-05-09),

2. 4714678 - Temperature sensitive strain of bovine viral diarrhoea virus (1987-12-22),

3. 4666837 - DNA sequences, recombinant DNA molecules and processes for producing the (1987-05-19),

4. 4649192 - Method for the isolation and purification of hepatitis B surface antigen (1987-03-10),

5. 4629567 - Alpha-1-antiprotease purification (1986-12-16),

6. 4618493 - Temperature sensitive strains of bovine viral diarrhoea virus, (1986-10-21),

7. 4465665 - Detoxified E. coli neurotoxin, preparation thereof and immunological (1984-08-14),

8. 4451446 - Process for the preparation of polysaccharide-protein complexes from (1984-05-29),

9. 4341763 - Methods of vaccinating humans against rotavirus infection (1982-07-27),

10. 4338296 - Influenza virus and process of producing a vaccine therefrom (1982-07-06),

11. 4318903 - Live influenza virus vaccine and the preparation thereof (1982-03-09),

12. 4314993 - Immunogenic E. coli ST enterotoxin derivatives and compositions (1982-02-09),

13. 4278662 - Attenuated influenza type A virus vaccine (1981-07-14),

14. 4235876 - Live Newcastle disease virus vaccine (1980-11-25),

Company Overview

Smithkline-Rit is a prominent organization based in Belgium, specializing in the development and manufacturing of innovative pharmaceutical products. The company focuses on research in various therapeutic areas, including infectious diseases and chronic conditions, leveraging advanced technologies to enhance drug efficacy and patient outcomes. With a commitment to improving global health, Smithkline-Rit collaborates with healthcare professionals and research institutions to drive advancements in medical science and deliver impactful healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#7 in

#201 in Belgium

#42,249 in the World

Smithkline-Rit

Forward Citations = 228

17 inventors:

Michele Lobmann (5 out of 5 patents)

Nathan Zygraich (4 out of 6 patents)

Gerard Florent (3 out of 3 patents)

4. Alex J Bollen (2 out of 3 patents)

5. Jean-Claude Delgoffe (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Smithkline-Rit. Retrieved from https://idiyas.com/company/smithkline-rit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…